SOX6-SOCS3通过STAT3信号通路调控缺氧诱导的人肺动脉平滑肌细胞增殖

王羽; 王授衔; 陈德伟; 刘宝; 高钰琪

doi:10.16016/j.1000-5404.202009149

您当前的位置：

首页 >

文章列表页 >

SOX6-SOCS3通过STAT3信号通路调控缺氧诱导的人肺动脉平滑肌细胞增殖

基础医学 | 更新时间：2026-01-09

- SOX6-SOCS3通过STAT3信号通路调控缺氧诱导的人肺动脉平滑肌细胞增殖
- SOX6-SOCS3 regulates hypoxia-induced proliferation of HPASMCs by targeting STAT3 signaling pathway
- 第三军医大学学报 2021年43卷第4期页码：295-302
- 作者机构：
  
  1.400038 重庆，陆军军医大学（第三军医大学）高原军事医学系：高原特需药品与器材研究室
  2.400038 重庆，陆军军医大学（第三军医大学）高原军事医学系：病理生理学教研室
  3.400038 重庆，陆军军医大学（第三军医大学）高原军事医学系：极端环境医学教育部重点实验室
  4.400038 重庆，陆军军医大学（第三军医大学）高原军事医学系：全军高原医学重点实验室
- 作者简介：
  
  [ 高钰琪，E-mail:gaoy66@yahoo.com GAO Yuqi, E-mail:gaoy66@yahoo.com
- 基金信息：
  
  全军后勤科技项目(AWS16J023)
- DOI：10.16016/j.1000-5404.202009149
  中图分类号： R322.121;R363.21;R364.31
- 收稿：2020-09-19，
  
  修回：2020-10-16，
  
  纸质出版：2021-04-15
- 稿件说明：
移动端阅览
王羽, 王授衔, 陈德伟, 等. SOX6-SOCS3通过STAT3信号通路调控缺氧诱导的人肺动脉平滑肌细胞增殖[J]. 第三军医大学学报, 2021,43(4):295-302.

Yu WANG, Shouxian WANG, Dewei CHEN, et al. SOX6-SOCS3 regulates hypoxia-induced proliferation of HPASMCs by targeting STAT3 signaling pathway[J]. Journal of Third Military Medical University, 2021, 43(4): 295-302.
王羽, 王授衔, 陈德伟, 等. SOX6-SOCS3通过STAT3信号通路调控缺氧诱导的人肺动脉平滑肌细胞增殖[J]. 第三军医大学学报, 2021,43(4):295-302. DOI： 10.16016/j.1000-5404.202009149.

Yu WANG, Shouxian WANG, Dewei CHEN, et al. SOX6-SOCS3 regulates hypoxia-induced proliferation of HPASMCs by targeting STAT3 signaling pathway[J]. Journal of Third Military Medical University, 2021, 43(4): 295-302. DOI： 10.16016/j.1000-5404.202009149.

摘要

目的

探究SRY盒转录因子6（SRY-Box transcription factor 6，SOX6）-细胞因子信号转导抑制因子3（suppressor of cytokine signaling 3，SOCS3）在缺氧诱导的人肺动脉平滑肌细胞（human pulmonary artery smooth cells，HPASMCs）增殖中的作用及其可能机制。

方法

① 4%O

缺氧处理HPASMCs分为3组：常氧组、缺氧24 h组、缺氧48 h组（

=3）。②使用小RNA干扰SOX6或SOCS3表达，干扰SOX6表达分为4组：si-SOX6-NC组、si-SOX6-1组、si-SOX6-2组、si-SOX6-3组（

=3），干扰SOCS3表达分为3组：si-SOCS3-NC组、si-SOCS3-1组、si-SOCS3-2组（

=3）。③构建慢病毒过表达SOX6细胞后缺氧处理48 h，分为4组：常氧对照组、过表达SOX6组、缺氧对照组、缺氧+过表达SOX6组（n=3）。④采用CCK-8检测各组细胞增殖，RT-qPCR、Western blot检测各组SOX6、SOCS3、磷酸化信号转导与转录激活因子3（phosphorylated-signal transduction and activators of transcription 3，p-STAT3）、增殖细胞核抗原（proliferating cell nuclear antigen，PCNA）的表达。

结果

缺氧可降低SOX6和SOCS3的表达（

0.01），不仅能诱导HPASMCs增殖（

0.05），还能显著上调p-STAT3、PCNA的表达（

0.05）。在常氧条件下，干扰SOX6或SOCS3可显著增强HPASMCs的增殖（

0.05），细胞中p-STAT3、PCNA的表达也显著升高（

0.01）。在缺氧条件下过表达SOX6可显著抑制缺氧诱导的HPASMCs增殖（

0.01），并显著降低p-STAT3、PCNA的表达（

0.01）。

结论

SOX6-SOCS3可抑制缺氧诱导的人肺动脉平滑肌细胞的增殖，其机制可能与抑制STAT3信号通路有关。

Abstract

Objective

To investigate the role of SRY-Box transcription factor 6 (SOX6)-suppressor of cytokine signaling 3 (SOCS3) on hypoxia-induced proliferation of human pulmonary artery smooth muscle cells (HPASMCs) and explore the possible mechanism.

Methods

① The HPASMCs were treated with 4% O

for 24 h or 48 h. ② siRNA was used to decrease the expression of SOX6 (si-SOX6-NC

si-SOX6-1

si-SOX6-2

si-SOX6-3) and SOCS3 (si-SOCS3-NC

si-SOCS3-1

si-SOCS3-2) in the cells. ③The HPASMCs with stable SOX6 overexpression induced by transfection with a lentiviral vector were exposed to hypoxia for 48 h

with the cells cultured in normoxia condition

or simple hypoxia condition as control. ④CCK-8 assay was used to testify the proliferation of the above groups of cells. The expression of SOX6

SOCS3

proliferating cell nuclear antigen (PCNA) and phosphorylated-signal transduction and activators of transcription 3 (p-STAT3) at mRNA and protein levels were detected by RT-qPCR and Western blotting

respectively.

Results

Hypoxia decreased the expression levels of SOX6 and SOCS3 (

0.01)

induced the proliferation of HPASMCs and up-regulated the levels of p-STAT3 and PCNA (

0.05). Under normoxia condition

the reduction of SOX6 or SOCS3 not only significantly increased the proliferation of HPASMCs (

0.05) butalso the levels of p-STAT3 and PCNA (

0.01). Under hypoxia

overexpression of SOX6 obviously suppressed hypoxia-induced proliferation and the expression levels of p-STAT3 and PCNA (

0.01).

Conclusion

SOX6-SOCS3 can suppress the hypoxia-induced proliferation of HPASMCs. Its mechanisms may be related to the inhibition of STAT3 signaling pathway.

关键词

Keywords

references

高钰琪.高原军事医学[M].重庆:重庆出版社, 2005. 54-74.

GAO Y Q. Plateau military medicine[M].Chongqing, Chongqing: Publishing House, 2005. 54-74.

LAI Y C, POTOKA K C, CHAMPION H C, et al . Pulmonary arterial hypertension: the clinical syndrome[J ] . Circ Res, 2014, 115(1): 115-130. DOI: 10.1161/circresaha.115.301146.

OLSCHEWSKI H, KOVACS G. ESC-Leitlinien 2015 zur pulmonalen hypertonie[J]. Herz, 2015, 40(8): 1055-1060. DOI: 10.1007/s00059-015-4381-5.

LAN N S H, MASSAM B D, KULKARNI S S, et al . Pulmonary arterial hypertension: pathophysiology and treatment[J ] . Diseases, 2018, 6(2): 38. DOI: 10.3390/diseases6020038.

DODSON M W, BROWN L M, ELLIOTT C G. Pulmonary arterial hypertension[J]. Heart Fail Clin, 2018, 14(3): 255-269. DOI: 10.1016/j.hfc.2018.02.003.

JAITOVICH A, JOURD'HEUIL D. A brief overview of nitric oxide and reactive oxygen species signaling in hypoxia-induced pulmonary hypertension[J].Pulm Vasc Redox Signal Heal Dis, 2017: 967: 71-81. DOI: 10.1007/978-3-319-63245-2_6.

THENAPPAN T, ORMISTON M L, RYAN J J, et al . Pulmonary arterial hypertension: pathogenesis and clinical management[J ] . BMJ, 2018, 360: j5492. DOI: 10.1136/bmj.j5492.

WANG Y, ZHONG B, WU Q, et al . Aldosterone contributed to pulmonary arterial hypertension development via stimulating aquaporin expression and pulmonary arterial smooth muscle cells proliferation[J ] . Pharmacology, 2020, 105(7/8): 405-415. DOI: 10.1159/000504228.

KWON M Y, HWANG N, PARK Y J, et al . NOD2 deficiency exacerbates hypoxia-induced pulmonary hypertension and enhances pulmonary vascular smooth muscle cell proliferation[J ] . Oncotarget, 2018, 9(16): 12671-12681. DOI: 10.18632/oncotarget.23912.

QIN M Z, QIN M B, LIANG Z H, et al . Effect of SOCS3 on lung injury in rats with severe acute pancreatitis through regulating JAK2/STAT3 signaling pathway[J ] . Eur Rev Med Pharmacol Sci, 2019, 23(22): 10123-10131. DOI: 10.26355/eurrev_201911_19582.

ZHANG J R, ZHU R H, HAN X P. MiR-410 affects the proliferation and apoptosis of lung cancer A549 cells through regulation of SOCS3/JAK-STAT signaling pathway[J].Eur Rev Med Pharmacol Sci, 2018, 22(18): 5994-6001. DOI: 10.26355/eurrev_201809_15934.

BAUS D, PFITZNER E. Specific function of STAT3, SOCS1, and SOCS3 in the regulation of proliferation and survival of classical Hodgkin lymphoma cells[J].Int J Cancer, 2006, 118(6): 1404-1413. DOI: 10.1002/ijc.21539.

HACKETT A R, LEE D H, DAWOOD A, et al . STAT3 and SOCS3 regulate NG2 cell proliferation and differentiation after contusive spinal cord injury[J ] . Neurobiol Dis, 2016, 89: 10-22. DOI: 10.1016/j.nbd.2016.01.017.

JOHNSON D E, O'KEEFE R A, GRANDIS J R. Targeting the IL-6/JAK/STAT3signalling axis in cancer[J]. Nat Rev Clin Oncol, 2018, 15(4): 234-248. DOI: 10.1038/nrclinonc.2018.8.

PARK S, KIM J K, OH C J, et al . Scoparone interferes with STAT3-induced proliferation of vascular smooth muscle cells[J ] . Exp Mol Med, 2015, 47(3): e145. DOI: 10.1038/emm.2014.113.

QIAN Z J, LI Y J, YANG H Y, et al . PDGFBB promotes proliferation and migration via regulating miR-1181/STAT3 axis in human pulmonary arterial smooth muscle cells[J ] . Am J Physiol Lung Cell Mol Physiol, 2018, 315(6): L965-L976. DOI: 10.1152/ajplung.00224.2018.

HEISS E H, LIU R, WALTENBERGER B, et al . Plumericin inhibits proliferation of vascular smooth muscle cells by blocking STAT3 signaling via S-glutathionylation[J ] . Sci Rep, 2016, 6: 20771. DOI: 10.1038/srep20771.

DANIEL J M, DUTZMANN J, BIELENBERG W, et al . Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation[J ] . Basic Res Cardiol, 2012, 107(3): 261. DOI: 10.1007/s00395-012-0261-9.

白莉, 余祖滨, 钱频, 等. SOCS3基因对缺氧大鼠肺动脉平滑肌细胞原癌基因c-myc mRNA表达及细胞增殖的影响[J].中国病理生理杂志, 2005, 21(12): 2310-2313.

BAI L, YU Z B, QIAN P, et al . Effects of SOCS3 gene on the expression of c-myc mRNA and proliferation of rat pulmonary arterial smooth musc le cells under hypoxia conditions[J ] . Chin J Pathophysiol, 2005, 21(12): 2310-2313.

CANTÙ C, IERARDI R, ALBORELLI I, et al . SOX6 enhances erythroid differentiation in human erythroid progenitors[J ] . Blood, 2011, 117(13): 3669-3679. DOI: 10.1182/blood-2010-04-282350.

LIU C F, LEFEBVRE V. The transcription factors SOX9 and SOX5/SOX6 cooperate genome-wide through super-enhancers to drivechondrogenesis[J]. Nucleic Acids Res, 2015, 43(17): 8183-8203. DOI: 10.1093/nar/gkv688.

LI J, LAI Y, LUO J, et al . SOX6 downregulation induces γ-globin in human β-thalassemia major erythroid cells[J ] . Biomed Res Int, 2017, 2017: 9496058. DOI: 10.1155/2017/9496058.

JIANG W, YUAN Q, JIANG Y, et al . Identification of Sox6 as a regulator of pancreatic cancer development[J ] . J Cell Mol Med, 2018, 22(3): 1864-1872. DOI: 10.1111/jcmm.13470.

LI Y C, LI C F, CHEN L B, et al . MicroRNA-766 targeting regulation of SOX6 expression promoted cell proliferation of human colorectal cancer[J ] . Onco Targets Ther, 2015, 8: 2981-2988. DOI: 10.2147/ott.s89459.

GUO X D, YANG M, GU H, et al . Decreased expression of SOX6 confers a poor prognosis in hepatocellular carcinoma[J ] . Cancer Epidemiol, 2013, 37(5): 732-736. DOI: 10.1016/j.canep.2013.05.002.

SPIEKERKOETTER E, KAWUT S M, DE JESUS PEREZ V A. New and emerging therapies for pulmonary arterial hypertension[J].Annu Rev Med, 2019, 70: 45-59. DOI: 10.1146/annurev-med-041717-085955.

HUETSCH J C, WALKER J, UNDEM C, et al . Rho kinase and Na+ /H+ exchanger mediate endothelin-1-induced pulmonary arterial smooth muscle cell proliferation and migration[J ] . Physiol Rep, 2018, 6(9): e13698. DOI: 10.14814/phy2.13698.

SONG Y, WU Y, SU X, et al . Activation of AMPK inhibits PDGF-induced pulmonary arterial smooth muscle cells proliferation and its potential mechanisms[J ] . Pharmacol Res, 2016, 107: 117-124. DOI: 10.1016/j.phrs.2016.03.010.

CHOWDHURY A, SARKAR J, PRAMANIK P K, et al . Cross talk between MMP2-Spm-Cer-S1P and ERK1/2 in proliferation of pulmonary artery smooth muscle cells under angiotensin Ⅱ stimulation[J ] . Arch Biochem Biophys, 2016, 603: 91-101. DOI: 10.1016/j.abb.2016.05.01 3.

YANG Y D, LI MM, XU G, et al . Nogo-B receptor directs mitochondria-associated membranes to regulate vascular smooth muscle cell proliferation[J ] . Int J Mol Sci, 2019, 20(9): 2319. DOI: 10.3390/ijms20092319.

GUAN Z, SHEN L, LIANG H, et al . Resveratrol inhibits hypoxia-induced proliferation and migration of pulmonary artery vascular smooth muscle cells by inhibiting the phosphoinositide 3-kinase/protein kinase B signaling pathway[J ] . Mol Med Rep, 2017, 16(2): 1653-1660. DOI: 10.3892/mmr.2017.6814.

ZHANG N, DONG M, LUO Y, et al . Danshensu prevents hypoxic pulmonary hypertension in rats by inhibiting the proliferation of pulmonary artery smooth muscle cells via TGF-β-smad3-associated pathway[J ] . Eur J Pharmacol, 2018, 820: 1-7. DOI: 10.1016/j.ejphar.2017.12.010.

NIE X, DAI Y, TAN J, et al . Α-Sola nine reverses pulmonary vascular remodeling and vascular angiogenesis in experimental pulmonary artery hypertension[J ] . J Hypertens, 2017, 35(12): 2419-2435. DOI: 10.1097/hjh.000000 0000001475.

LI Z W, WANG Y. MiR-96 targets SOX6 and promotes proliferation, migration, and invasion of hepatocellular carcinoma[J].Biochem Cell Biol, 2018, 96(3): 365-371. DOI: 10.1139/bcb-2017-0183.

LI Y, XIAO M, GUO F. The role of Sox6 and Netrin-1 in ovarian cancer cell growth, invasiveness, and angiogenesis[J].Tumour Biol, 2017, 39(5): 1010428317705508. DOI: 10.1177/1010428317705508.

YU Y, WANG Z, SUN D, et al . miR-671 promotes prostate cancer cell proliferation by targeting tumor suppressor SOX6[J ] . Eur J Pharmacol, 2018, 823: 65-71. DOI: 10.1016/j.ejphar.2018.01.016.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

缺氧通过TAZ-H2A.Z轴调控H2A.Z染色质沉积促进肺泡上皮细胞增殖的研究

DNase 2α在缺氧诱导大鼠肺动脉平滑肌细胞增殖中的作用及机制研究

缺氧诱导线粒体DNA释放后激活cGAS-STING通路促进肺动脉平滑肌细胞增殖

人STAT3重组腺病毒的制备及其对胃癌细胞株SGC-7901增殖的影响

缺氧通过驱动M1巨噬细胞极化诱发睾丸间质细胞溶酶体依赖性死亡导致生精功能受损